| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 267.75 | 244.29 | 9.603 | 278.45 | -3.842 |
| Gross Profit (Loss) | 98.81 | 90.81 | 8.809 | 114.55 | -13.74 |
| Operational Profit (Loss) | 47.16 | 50.66 | -6.908 | 42.9 | 9.93 |
| Net Profit (Loss) after Zakat and Tax | 40.3 | 39.1 | 3.069 | 35.54 | 13.393 |
| Total Comprehensive Income | 41.15 | 40.39 | 1.881 | 37.25 | 10.469 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 546.2 | 450.98 | 21.114 |
| Gross Profit (Loss) | 213.37 | 157.29 | 35.653 |
| Operational Profit (Loss) | 90.06 | 87.72 | 2.667 |
| Net Profit (Loss) after Zakat and Tax | 75.84 | 64.05 | 18.407 |
| Total Comprehensive Income | 78.4 | 66.83 | 17.312 |
| Total Share Holders Equity (after Deducting Minority Equity) | 1,717.06 | 1,632.96 | 5.15 |
| Profit (Loss) per Share | 0.63 | 0.53 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | The net profit of the current quarter has increased compared with the net profit of the same quarter last year due to the following: |
1. The increase in medical services segement revenues resulted from the recovery of outpatient's activities reaching levels before the Corona pandemic.
2. The increase in the revenues of pharmaceutical product segment.
3. The decrease in finance costs due to lower loans balances and lower lending cost.
4. The decrease in the zakat expense for the current quarter due to the decrease in the zakat base.
1.The decrease in expected credit losses for current quarter compared with the previous quarter.
2. The decrease in some items of operating, administrative and general expenses.
1. The increase in medical services segement revenues resulted from the recovery of outpatient's activities reaching levels before the Corona pandemic.
2. The increase in the revenues of pharmaceutical product segment.
3. The decrease in finance costs due to lower loans balances and lower lending cost.
4. The decrease in the zakat expense for the current period due to the decrease in the zakat base.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.